Global Liposome Drug Delivery Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030

Global Liposome Drug Delivery Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030

Liposomes have been used to improve the therapeutic index of new or established drugs by modifying drug absorption, reducing metabolism, prolonging biological half-life or reducing toxicity. Drug distribution is then controlled primarily by properties of the carrier and no longer by physico-chemical characteristics of the drug substance only. In a liposome drug product, the drug substance is contained in liposomes. Typically, water soluble drugs are contained in the aqueous compartment(s) and hydrophobic drugs are contained in the lipid layer(s) of the liposomes. Release of drugs from liposome formulations can be modified by the presence of polyethylene glycol and/or cholesterol or other potential additives in the liposome.

According to our (Global Info Research) latest study, the global Liposome Drug Delivery market size was valued at US$ 4376 million in 2023 and is forecast to a readjusted size of USD 9892 million by 2030 with a CAGR of 12.5% during review period.

Global Liposome Drug Delivery key players include Gilead Sciences, Pacira, Sun Pharmaceutical, Johnson & Johnson, Luye Pharma, etc. Global top five manufacturers hold a share about 60%. North America is the largest market, with a share about 40%, followed by Europe and Asia-Pacific, both with a share about 30 percent. In terms of product, Liposomal Doxorubicin is the largest segment, with a share about 40%. And in terms of application, the largest application is Cancer & Tumor Therapy, followed by Fungal Infection Therapy, etc.

This report is a detailed and comprehensive analysis for global Liposome Drug Delivery market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2024, are provided.

Key Features:

Global Liposome Drug Delivery market size and forecasts, in consumption value ($ Million), sales quantity (K Vial), and average selling prices (USD/Vial), 2019-2030

Global Liposome Drug Delivery market size and forecasts by region and country, in consumption value ($ Million), sales quantity (K Vial), and average selling prices (USD/Vial), 2019-2030

Global Liposome Drug Delivery market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (K Vial), and average selling prices (USD/Vial), 2019-2030

Global Liposome Drug Delivery market shares of main players, shipments in revenue ($ Million), sales quantity (K Vial), and ASP (USD/Vial), 2019-2024

The Primary Objectives in This Report Are:

To determine the size of the total market opportunity of global and key countries

To assess the growth potential for Liposome Drug Delivery

To forecast future growth in each product and end-use market

To assess competitive factors affecting the marketplace

This report profiles key players in the global Liposome Drug Delivery market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Gilead Sciences, Pacira, Sun Pharmaceutical, Johnson & Johnson, Luye Pharma, Sigma-Tau, Ipsen (Onivyde), CSPC, Teva Pharmaceutical, Novartis, etc.

This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.

Market Segmentation

Liposome Drug Delivery market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.

Market segment by Type
Liposomal Doxorubicin
Liposomal Amphoteracin B
Liposomal Paclitaxel
Others

Market segment by Application
Fungal Infection Therapy
Cancer & Tumor Therapy
Others

Major players covered
Gilead Sciences
Pacira
Sun Pharmaceutical
Johnson & Johnson
Luye Pharma
Sigma-Tau
Ipsen (Onivyde)
CSPC
Teva Pharmaceutical
Novartis
Fudan-Zhangjiang

Market segment by region, regional analysis covers

North America (United States, Canada, and Mexico)

Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)

Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)

South America (Brazil, Argentina, Colombia, and Rest of South America)

Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)

The content of the study subjects, includes a total of 15 chapters:

Chapter 1, to describe Liposome Drug Delivery product scope, market overview, market estimation caveats and base year.

Chapter 2, to profile the top manufacturers of Liposome Drug Delivery, with price, sales quantity, revenue, and global market share of Liposome Drug Delivery from 2019 to 2024.

Chapter 3, the Liposome Drug Delivery competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.

Chapter 4, the Liposome Drug Delivery breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2019 to 2030.

Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2019 to 2030.

Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2019 to 2024.and Liposome Drug Delivery market forecast, by regions, by Type, and by Application, with sales and revenue, from 2025 to 2030.

Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.

Chapter 13, the key raw materials and key suppliers, and industry chain of Liposome Drug Delivery.

Chapter 14 and 15, to describe Liposome Drug Delivery sales channel, distributors, customers, research findings and conclusion.